An International Prophylaxis Study Group (IPSG) survey of prophylaxis in adults with severe haemophilia

Manuel Carção(Hospital for Sick Children), Louis M. Aledort(Icahn School of Medicine at Mount Sinai), Laura Avila(Hospital for Sick Children), Cindy Leissinger(National Institutes of Health), Victor S. Blanchette(University of Toronto)
Haemophilia
April 21, 2017
10.1111/hae.13238
Cited by 6

Related Papers

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
|PubMed|2001|803
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613
A More Uniform Measurement of Factor VIII Inhibitors
|Thrombosis and Haemostasis|1975|587